Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Communicative & Integrative Biology
|
June 11, 2009
Plants, endosymbionts and parasites: Abscisic acid and calcium signaling
Kisaburo Nagamune, Liming Xiong, Eduardo Chini, et al.
Journal of Molecular and Cellular Cardiology
|
February 25, 2018
Genetic deletion of CD38 confers post-ischemic myocardial protection through preserved pyridine nucleotides
James Boslett, Moustafa Helal, Eduardo Chini, et al.
The Journal of Clinical Investigation
|
July 1, 2022
Mitochondrial dysfunction in cell senescence and aging
Satomi Miwa, Sonu Kashyap, Eduardo Chini, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 18, 2015
Deleted in Breast Cancer 1 Suppresses B Cell Activation through RelB and Is Regulated by IKKα Phosphorylation
Sinyi Kong, Hongxin Dong, Jianxun Song, et al.
Cancer Medicine
|
October 16, 2023
Immunomodulatory properties of CD38 antibodies and their effect on anticancer efficacy in multiple myeloma
Kamlesh Bisht, Taro Fukao, Marielle Chiron, et al.
Biochemical and Biophysical Research Communications
|
April 13, 2019
The NADase CD38 is induced by factors secreted from senescent cells providing a potential link between senescence and age-related cellular NAD<sup>+</sup> decline
Claudia Chini, Kelly A Hogan, Gina M Warner, et al.
Kidney360
|
December 12, 2025
Emerging Therapies in Autosomal Dominant Polycystic Kidney Disease
Christopher Y Chen, Mohamad Hadla, Ibrahim Khambati, et al.
Blood Advances
|
May 19, 2020
Targeting CD38 is lethal to Breg-like chronic lymphocytic leukemia cells and Tregs, but restores CD8+ T-cell responses
Alak Manna, Timothy Kellett, Sonikpreet Aulakh, et al.
Frontiers in Immunology
|
October 29, 2025
Inhibition of CD38 enzyme activity on engrafted human immune cells enhances NAD+ metabolism and inhibits inflammation in an <i>in-vivo</i> model of xeno-GvHD
Ghenima Ahmil-Boiteau, Pranjali Dalvi, Kevin Dang, et al.
Oncotarget
|
September 18, 2015
HSulf-1 deficiency dictates a metabolic reprograming of glycolysis and TCA cycle in ovarian cancer
Susmita Mondal, Debarshi Roy, Juliana Camacho-Pereira, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Communicative & Integrative Biology
|
June 11, 2009
Plants, endosymbionts and parasites: Abscisic acid and calcium signaling
Kisaburo Nagamune, Liming Xiong, Eduardo Chini, et al.
Journal of Molecular and Cellular Cardiology
|
February 25, 2018
Genetic deletion of CD38 confers post-ischemic myocardial protection through preserved pyridine nucleotides
James Boslett, Moustafa Helal, Eduardo Chini, et al.
The Journal of Clinical Investigation
|
July 1, 2022
Mitochondrial dysfunction in cell senescence and aging
Satomi Miwa, Sonu Kashyap, Eduardo Chini, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 18, 2015
Deleted in Breast Cancer 1 Suppresses B Cell Activation through RelB and Is Regulated by IKKα Phosphorylation
Sinyi Kong, Hongxin Dong, Jianxun Song, et al.
Cancer Medicine
|
October 16, 2023
Immunomodulatory properties of CD38 antibodies and their effect on anticancer efficacy in multiple myeloma
Kamlesh Bisht, Taro Fukao, Marielle Chiron, et al.
Biochemical and Biophysical Research Communications
|
April 13, 2019
The NADase CD38 is induced by factors secreted from senescent cells providing a potential link between senescence and age-related cellular NAD<sup>+</sup> decline
Claudia Chini, Kelly A Hogan, Gina M Warner, et al.
Kidney360
|
December 12, 2025
Emerging Therapies in Autosomal Dominant Polycystic Kidney Disease
Christopher Y Chen, Mohamad Hadla, Ibrahim Khambati, et al.
Blood Advances
|
May 19, 2020
Targeting CD38 is lethal to Breg-like chronic lymphocytic leukemia cells and Tregs, but restores CD8+ T-cell responses
Alak Manna, Timothy Kellett, Sonikpreet Aulakh, et al.
Frontiers in Immunology
|
October 29, 2025
Inhibition of CD38 enzyme activity on engrafted human immune cells enhances NAD+ metabolism and inhibits inflammation in an <i>in-vivo</i> model of xeno-GvHD
Ghenima Ahmil-Boiteau, Pranjali Dalvi, Kevin Dang, et al.
Oncotarget
|
September 18, 2015
HSulf-1 deficiency dictates a metabolic reprograming of glycolysis and TCA cycle in ovarian cancer
Susmita Mondal, Debarshi Roy, Juliana Camacho-Pereira, et al.
Page
of 2